BioSpace News Archive

Biotech Beach

UCSC Release: Bioinformatics Leaders Partner to Build Platform for NIH Data Commons

Bioinformatics experts now view cloud-based computing and data storage as the most effective way to manage and use these rapidly growing biomedical datasets.

November 6, 2017
·
3 min read
Drug Development

Anavex Life Sciences Presents New Clinical Data of Investigational Alzheimer’s Disease Treatment ANAVEX2-73 at 2017 Clinical Trials on Alzheimer’s Disease Meeting

Data presented include new results from the Phase 1 study (ANAVEX®2-73-001), the Phase 2a study (ANAVEX®2-73-002), and data from the first year of the Phase 2a long-term extension study (ANAVEX®2-73-003).

November 6, 2017
·
7 min read
BioMidwest

ACR/ARHP 2017: New Analysis Shows Rheumatoid Arthritis Patients Treated with Baricitinib Reported Greater Improvements in Pain Compared to Adalimumab or Placebo

A new post-hoc analysis of the Phase 3 RA-BEAM study disclosing outcomes of patient-reported levels of pain control will be presented today at the American College of Rheumatology ACR/ARHP Annual Meeting in San Diego, Calif.

November 6, 2017
·
9 min read
Biotech Bay

HeartFlow Announces Decision by Centers for Medicare & Medicaid Services to Assign a New Technology Payment Classification to HeartFlow FFRct Analysis

Under the APC payment system, hospitals enrolled in Medicare that bill CMS for the HeartFlow FFRct Analysis for Medicare patients will be eligible for reimbursement at a rate of $1,450.50 for the technical component of the test.

November 6, 2017
·
6 min read
Biotech Bay

Counsyl Celebrates Anniversary With $80M Funding Round

The increased funding showcases investor confidence in Counsyl’s leading genetic screening products and business model.

November 6, 2017
·
3 min read
Pharm Country

Nephros Announces Approval of $1.9 Million in NJEDA NOL Program Tax Credits

Nephros announced today the receipt of $1.9 million in tax credit certificates from New Jersey Economic Development Authority (NJEDA), which are expected be sold later this quarter for over $1.75 million in net proceeds.

November 6, 2017
·
3 min read
Pharm Country

Tauriga Sciences Fully Retires $45,000 USD Face Value 8.00% Convertible Debenture Issued to GS Capital Partners LLC on April 27, 2017

This Note was retired exclusively through a one-time conversion exercised by GS Capital on November 2, 2017 for 83,597,839 shares of the Company’s common stock.

November 6, 2017
·
3 min read